|
| Press Releases |
|
 |
|
| Saturday, June 22, 2019 |
|
|
ENVY (IDX: ENVY) IPO Lepas 600 Juta Saham |
| Perusahaan penyedia jasa teknologi informasi, PT Envy Technologies Indonesia, Tbk, (ENVY) akan melakukan penawaran umum perdana saham atau Initial Public Offering (IPO). more info >> |
|
|
Envy Technologies Indonesia (IDX:ENVY) IPO set July 8 |
| PT Envy Technologies Indonesia Tbk (IDX: ENVY), InfoTech service provider, has announced its initial public offering (IPO) on July 8. ENVY plans to offer 600 million (.6 billion) new shares, or 33% of its increased paid-up capital, including 18 million share Employee Stock Allocation (ESA), together with 1,200 million (1,2 billion) normal shares subsequently offered on the secondary market on behalf of Company shareholders. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Shoucheng Holdings (0697.HK) Proposes HK$780 Million Dividend: HK$6 Billion in Cumulative Payouts Over Eight Years Solidifies Long-Term Value Logic
Mar 27, 2026 23:00 HKT/SGT
|
|
|
首程控股(0697.HK)擬派息7.8億港元 八年持續分紅60億港元夯實長期價值邏輯
Mar 27, 2026 23:00 HKT/SGT
|
|
|
益美国际(01870.HK) 优化供应链 加速储能产品布局 夯实全球产业能力
Mar 27, 2026 21:35 HKT/SGT
|
|
|
Everest Medicines Enters into Asset Purchase Agreement for Etripamil Nasal Spray, Expanding Cardiovascular Footprint
Mar 27, 2026 19:40 HKT/SGT
|
|
|
Xunce Technology's Revenue Surges 449% Half-on-Half: Is a Structural Revaluation to a Hundred-Billion Market Cap Camp on the Horizon?
Mar 27, 2026 19:19 HKT/SGT
|
|
|
Application Submitted for LENVIMA(R) (lenvatinib) in Japan Seeking Approval of Additional Dosage and Administration for Combination with WELIREG(R) (belzutifan) for Renal Cell Carcinoma that has Progressed After Chemotherapy
Mar 27, 2026 20:14 JST
|
|
|
迅策科技業績環比激增449% 結構性重估或進入千億市值陣營？
Mar 27, 2026 19:12 HKT/SGT
|
|
|
迅策科技业绩环比激增449% 结构性重估或进入千亿市值阵营？
Mar 27, 2026 19:04 HKT/SGT
|
|
|
Hitachi and MUFG Bank expand NextGen model to finance vehicles and charging infrastructure for decarbonized mobility
Mar 27, 2026 19:44 JST
|
|
|
Analogue 2025 Annual Results Profit Attributable to Owners of the Company Increases 23.5% to HK$167.0 Million
Mar 27, 2026 18:38 HKT/SGT
|
|
|
安樂工程公佈2025年全年業績 本公司擁有人應佔溢利增23.5%至1.670億港元
Mar 27, 2026 18:29 HKT/SGT
|
|
|
安乐工程公布2025年全年业绩 本公司拥有人应占溢利增23.5%至1.670亿港元
Mar 27, 2026 18:18 HKT/SGT
|
|
|
多維驅動全域突破 海天味業2025年交出高品質發展成績單
Mar 27, 2026 18:08 HKT/SGT
|
|
|
多维驱动全局突破 海天味业2025年交出高质量发展成绩单
Mar 27, 2026 17:57 HKT/SGT
|
|
|
Eisai and Nuvation Bio Announce Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer Validated by the European Medicines Agency
Mar 27, 2026 18:19 JST
|
|
|
|
|
More News >> |
|
|
|
|
|
